A
ALX Oncology Holdings Inc. (ALXO)
NMS – Real Time Price. Currency in USD
2.03
-0.05 (-2.40%)
At close: May 12, 2026, 4:00 PM EDT
2.01
-0.02 (-0.99%)
Pre-market: May 13, 2026, 4:19 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
2.03
-0.05 (-2.40%)
At close: May 12, 2026, 4:00 PM EDT
2.01
-0.02 (-0.99%)
Pre-market: May 13, 2026, 4:19 AM EDT
No Data
There are no news for this stock.
Company's cash reserves $16.4M significantly exceed its total debt $14.8M, ensuring strong financial flexibility
Total current assets $50.7M exceed Total current liabilities $24.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-60.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$19.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.07 | 6.05 | 10 | |
| Quick ratio | 2.07 | 5.63 | 10 | |
| Debt to Equity | 0.57 | 0.30 | 7.0 | |
| Debt to Assets | 0.25 | 1.04 | 7.0 | |
| Interest coverage | -60.11 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -836K | -872K | -706K | -706K |
| Operating Income | -127M | -170M | -142M | -101M | -101M |
| Net Income | -123M | -161M | -135M | -102M | -102M |
| EBITDA | -126M | -169M | -142M | -100M | -100M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 64.75 | 5.5 |
| Next quarter | N/A | 56.76 | 5.5 |
| Current year | N/A | 62.81 | 5.5 |
| Next year | N/A | 13.95 | 4.5 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -3.17 | -2.43 | -10.95 | 3.3 |
| Y/Y | 999 | 21.65 | 23.64 | 40.73 | 10 |
| 3y average | 999 | 3.5 | 11.32 | -2.36 | 5.5 |
| 5y average | 779.2 | -23.97 | 2.52 | -23.66 | 4.0 |
| Weighted average score | 5.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |